Portal de investigación
Massively parallel characterization of CRISPR activator efficacy in human induced pluripotent stem cells and neurons.
Fecha de publicación:
Fecha Ahead of Print:
Autores de CIPF
Participantes ajenos a CIPF
- Wu Q
- Wu J
- Karim K
- Chen X
- Wang T
- Iwama S
- Keen P
- Kotter MR
- Bassett A
Grupos de Investigación
Abstract
CRISPR activation (CRISPRa) is an important tool to perturb transcription, but its effectiveness varies between target genes. We employ human pluripotent stem cells with thousands of randomly integrated barcoded reporters to assess epigenetic features that influence CRISPRa efficacy. Basal expression levels are influenced by genomic context and dramatically change during differentiation to neurons. Gene activation by dCas9-VPR is successful in most genomic contexts, including developmentally repressed regions, and activation level is anti-correlated with basal gene expression, whereas dCas9-p300 is ineffective in stem cells. Certain chromatin states, such as bivalent chromatin, are particularly sensitive to dCas9-VPR, whereas constitutive heterochromatin is less responsive. We validate these rules at endogenous genes and show that activation of certain genes elicits a change in the stem cell transcriptome, sometimes showing features of differentiated cells. Our data provide rules to predict CRISPRa outcome and highlight its utility to screen for factors driving stem cell differentiation.
Datos de la publicación
- ISSN/ISSNe:
- 1097-2765, 1097-4164
- Tipo:
- Article
- Páginas:
- 1125-
- PubMed:
- 36917981
MOLECULAR CELL CELL PRESS
Citas Recibidas en Web of Science: 15
Documentos
- No hay documentos
Filiaciones
Keywords
- CRISPR activation, CRISPRa, VPR, chromatin, epigenetic, hiPSC, iNeurons, p300, single cell, stem cells
Proyectos asociados
New players in human BAT differentiation and activation
Investigador Principal: STEFANIA CAROBBIO
COMMISSION OF EUROPEAN COMMUNITIES . 2021
UNA NUEVA APROXIMACION TERAPEUTICA A LA OBESIDAD: MECANISMOS MOLECULARES DE LA DISOCIACION ENTRE LA EXPANSION DE LA MASA GRASA Y EL DESARROLLO DE COMPLICACIONES METABOLICAS
Investigador Principal: STEFANIA CAROBBIO
MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2022
Neuromodulación no invasiva de la termogénesis del tejido adiposo pardo como nueva terapia para enfermedades metabólicas
Investigador Principal: STEFANIA CAROBBIO
2022
Red Nuevos retos en investigación sobre plasticidad adiposa. Coordina Universitat de Barcelona
Investigador Principal: STEFANIA CAROBBIO
MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2023